Bayer will present new data from the ARANOTE trial evaluating ultra-low prostate-specific antigen responses with NUBEQA ® ...

Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...

Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...

The treatment of prostate cancer in Uganda follows similar principles to those used worldwide, including surgery, radiation ...

Erleada reduced the risk of death by more than 20% compared with other treatments in metastatic castration-sensitive prostate ...

The widow of a stalwart WA farmer who took his life amid a battle with prostate cancer is calling on politicians to ‘stand up ...

But he never seemed able to see the same doctor, and when a prostate specific antigen test came back in 2016 showing his ...

Prostate cancer has long been one of Canada’s most prevalent, yet under-discussed health threats. It is the most commonly ...

A group of senior gym-goers who got their prostates checked at roughly the same time were shocked to find almost half of them had early signs of cancer. The nine men meet regularly to work out at ...

A group of Mandurah men are meeting twice a week to workout and ward off the mental and physical side effects in their fight ...

The phase 2a LEGION-100 trial seeks to evaluate the safety and effectiveness of the SYNC-T/SV-102 combination therapy for treating metastatic castration-resistant prostate cancer (mCRPC) and to ...

A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was confirmed by data from a new study. Here is a roundup of March 2025 U.S. FDA ...